<SEC-DOCUMENT>0001104659-20-127416-index.html : 20201119
<SEC-HEADER>0001104659-20-127416.hdr.sgml : 20201119
<ACCEPTANCE-DATETIME>20201119172402
ACCESSION NUMBER:		0001104659-20-127416
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20201119
DATE AS OF CHANGE:		20201119
EFFECTIVENESS DATE:		20201119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Olema Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001750284
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300409740
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-250209
		FILM NUMBER:		201329681

	BUSINESS ADDRESS:	
		STREET 1:		512 2ND STREET, 4TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
		BUSINESS PHONE:		(415) 651-3316

	MAIL ADDRESS:	
		STREET 1:		512 2ND STREET, 4TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>tm2027048-16_s8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: tm2027048-16_s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2027048d16_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: tm2027048d16_ex5-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm2027048d16_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: tm2027048d16_ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>tm2027048d16_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
Document 4 - file: tm2027048d16_ex99-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>5
<FILENAME>tm2027048d16_ex99-6.htm
<DESCRIPTION>EXHIBIT 99.6
<TEXT>
Document 5 - file: tm2027048d16_ex99-6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2027048d16_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tm2027048d16_ex5-1img001.jpg

</DOCUMENT>
</SEC-DOCUMENT>